(Q38568602)

4 September 2017

Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma (English)

1 reference

4 September 2017

1 reference

0 references

Yongguang Tao

1

1 reference

4 September 2017

Ying Shi

2

1 reference

4 September 2017

Jiantao Jia

3

1 reference

4 September 2017

Yiqun Jiang

4

1 reference

4 September 2017

Lifang Yang

5

1 reference

4 September 2017

Ya Cao

6

1 reference

4 September 2017

18 August 2015

1 reference

Expert Reviews in Molecular Medicine

4 September 2017

1 reference

4 September 2017

17

1 reference

4 September 2017

e15

1 reference

Immunoglobulin alpha heavy chain derived from human epithelial cancer cells promotes the access of S phase and growth of cancer cells.

4 September 2017

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Nucleotide sequence analysis of a transforming gene isolated from nasopharyngeal carcinoma cell line CNE2: an aberrant human immunoglobulin kappa light chain which lacks variable region

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Expression of immunoglobulin kappa light chain constant region in abnormal human cervical epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Immunoglobulin expression and its biological significance in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Heterogeneity of aberrant immunoglobulin expression in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Expression of SNC73, a transcript of the immunoglobulin alpha-1 gene, in human epithelial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Immunoglobulin expression in non-lymphoid lineage and neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Protein tyrosine sulfation: a critical posttranslation modification in plants and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Existence of distinct tyrosylprotein sulfotransferase genes: molecular characterization of tyrosylprotein sulfotransferase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Sequential tyrosine sulfation of CXCR4 by tyrosylprotein sulfotransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Tyrosine sulfation is prevalent in human chemokine receptors important in lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Human anti-CXCR4 antibodies undergo VH replacement, exhibit functional V-region sulfation, and define CXCR4 antigenic heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 alpha association and HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Human B cells immortalized with Epstein-Barr virus upregulate CCR6 and CCR10 and downregulate CXCR4 and CXCR5

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr virus latent membrane protein 1 mediates serine 25 phosphorylation and nuclear entry of annexin A2 via PI-PLC-PKCalpha/PKCbeta pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr virus latent membrane protein 1 mediates phosphorylation and nuclear translocation of annexin A2 by activating PKC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

A census of amplified and overexpressed human cancer genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Nuclear epidermal growth factor receptor interacts with transcriptional intermediary factor 2 to activate cyclin D1 gene expression triggered by the oncoprotein latent membrane protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Nuclear EGFR as a molecular target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Nuclear trafficking of the epidermal growth factor receptor family membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Quercetin-induced apoptosis prevents EBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Nuclear EGFR contributes to acquired resistance to cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Latent membrane protein 1 encoded by Epstein-Barr virus induces telomerase activity via p16INK4A/Rb/E2F1 and JNK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

ErbB receptors: new insights on mechanisms and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-kappaB p65 in human nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Tyrosine phosphorylation controls PCNA function through protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Viral oncoprotein LMP1 disrupts p53-induced cell cycle arrest and apoptosis through modulating K63-linked ubiquitination of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Ubiquitination of MDM2 modulated by Epstein-Barr virus encoded latent membrane protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr virus-encoded LMP1 triggers regulation of the ERK-mediated Op18/stathmin signaling pathway in association with cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

EBV-encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Role of STAT3/5 and Bcl-2/xL in 2-methoxyestradiol-induced endoreduplication of nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

A therapeutic approach to nasopharyngeal carcinomas by DNAzymes targeting EBV LMP-1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Non-cell-autonomous tumor suppression by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Direct phage to intrabody screening (DPIS): demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr virus latent membrane protein 1 (LMP1) that block NF-kappaB transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

A human Fab-based immunoconjugate specific for the LMP1 extracellular domain inhibits nasopharyngeal carcinoma growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Humoral immune responses to Epstein-Barr virus encoded tumor associated proteins and their putative extracellular domains in nasopharyngeal carcinoma patients and regional controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Apoptosis modulation of Epstein-Barr virus-encoded latent membrane protein 1 in the epithelial cell line HeLa is stimulus-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Induction of therapeutic antibodies by vaccination against external loops of tumor-associated viral latent membrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Latent membrane protein-1 of Epstein-Barr virus inhibits cell growth and induces sensitivity to cisplatin in nasopharyngeal carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Modulation of Epstein-Barr virus latent membrane protein 1 activity by intrabodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

The need and challenges for development of an Epstein-Barr virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Inhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr virus latent membrane protein 1: structure and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--β1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Modulation of the autophagy pathway by human tumor viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr virus latent membrane protein 1 suppresses the growth-inhibitory effect of retinoic acid by inhibiting retinoic acid receptor-beta2 expression via DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Intracellular signaling controlled by the endosomal-exosomal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Lipid rafts as a membrane-organizing principle

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Nasopharyngeal carcinoma-associated Epstein-Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Virology. Epstein-Barr virus turns 50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Microbiome and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Localization of the Epstein-Barr virus protein LMP 1 to exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Direct immunosuppressive effects of EBV-encoded latent membrane protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Human viral oncogenesis: a cancer hallmarks analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Spectrum of Epstein-Barr virus-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

The search for infectious causes of human cancers: where and why.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Multiple roles of LMP1 in Epstein-Barr virus induced immune escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Activation of the Ig Iα1 promoter by the transcription factor Ets-1 triggers Ig Iα1-Cα1 germline transcription in epithelial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Characterization of the human immunoglobulin kappa gene 3' enhancer: functional importance of three motifs that demonstrate B-cell-specific in vivo footprints

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Two regulatory elements for immunoglobulin kappa light chain gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Expression and secretion of immunoglobulin alpha heavy chain with diverse VDJ recombinations by human epithelial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Fisetin inhibits migration, invasion and epithelial-mesenchymal transition of LMP1-positive nasopharyngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Molecular characterization and clinical implications of spindle cells in nasopharyngeal carcinoma: a novel molecule-morphology model of tumor progression proposed

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Correction: OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Effect of DNAzymes targeting Akt1 on cell proliferation and apoptosis in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB regulated ATM expression

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Promoter hypermethylation of CCNA1, RARRES1, and HRASLS3 in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Epstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Dynamics of the cellular metabolome during human cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

An invertebrate Warburg effect: a shrimp virus achieves successful replication by altering the host metabolome via the PI3K-Akt-mTOR pathway

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Progress, prospects, and problems in Epstein-Barr virus vaccine development

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

LMP1-induced cell death may contribute to the emergency of its oncogenic property.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.13

7 January 2021

Identifiers

DOI

10.1017/ERM.2015.13

1 reference

4 September 2017

1 reference